0002097084-25-000001.txt : 20251204 0002097084-25-000001.hdr.sgml : 20251204 20251204135709 ACCESSION NUMBER: 0002097084-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251204 DATE AS OF CHANGE: 20251204 EFFECTIVENESS DATE: 20251204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medici Therapeutics, Inc. CENTRAL INDEX KEY: 0002097084 ORGANIZATION NAME: EIN: 883875735 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-565786 FILM NUMBER: 251548960 BUSINESS ADDRESS: STREET 1: 230 COMMONWEALTH AVENUE STREET 2: APT. 4 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 407-733-2808 MAIL ADDRESS: STREET 1: 230 COMMONWEALTH AVENUE STREET 2: APT. 4 CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0002097084 Medici Therapeutics, Inc. 230 COMMONWEALTH AVENUE APT. 4 BOSTON MA MASSACHUSETTS 02116 407-733-2808 DELAWARE Marble Therapeutics, Inc. None Corporation true 2021 Denitsa Milanova 230 Commonwealth Avenue Apt. 4 Boston MA MASSACHUSETTS 02116 Executive Officer Director David Thompson 230 Commonwealth Avenue Apt. 4 Boston MA MASSACHUSETTS 02116 Executive Officer Nicholas P. Restifo 230 Commonwealth Avenue Apt. 4 Boston MA MASSACHUSETTS 02116 Executive Officer Matthew Rabinowitz 230 Commonwealth Avenue Apt. 4 Boston MA MASSACHUSETTS 02116 Director Biotechnology Decline to Disclose 06b false 2025-11-20 false true true 0 14791454 14791454 0 false 11 0 0 0 false Medici Therapeutics, Inc. /s/ Denitsa Milanova Denitsa Milanova Chief Executive Officer 2025-12-04